Gallagher Fiduciary Advisors LLC Makes New Investment in Philip Morris International Inc. $PM

Gallagher Fiduciary Advisors LLC bought a new stake in Philip Morris International Inc. (NYSE:PMFree Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 3,687 shares of the company’s stock, valued at approximately $667,000.

Several other institutional investors have also modified their holdings of the company. Capital World Investors lifted its position in Philip Morris International by 2.8% in the 4th quarter. Capital World Investors now owns 132,355,726 shares of the company’s stock valued at $21,230,315,000 after purchasing an additional 3,579,399 shares during the last quarter. BlackRock Inc. grew its position in Philip Morris International by 0.4% in the 2nd quarter. BlackRock Inc. now owns 108,039,522 shares of the company’s stock worth $19,545,430,000 after purchasing an additional 444,449 shares during the last quarter. Capital International Investors increased its stake in shares of Philip Morris International by 13.7% in the fourth quarter. Capital International Investors now owns 101,377,875 shares of the company’s stock valued at $16,262,967,000 after purchasing an additional 12,227,004 shares during the period. Capital Research Global Investors increased its stake in shares of Philip Morris International by 25.3% in the fourth quarter. Capital Research Global Investors now owns 54,559,706 shares of the company’s stock valued at $8,751,407,000 after purchasing an additional 11,013,173 shares during the period. Finally, GQG Partners LLC bought a new stake in shares of Philip Morris International during the second quarter valued at approximately $8,220,008,000. Institutional investors own 78.63% of the company’s stock.

Key Philip Morris International News

Here are the key news stories impacting Philip Morris International this week:

  • Positive Sentiment: FDA authorization strengthens ZYN growth prospects. The FDA authorized 11 ZYN ULTRA nicotine-pouch products, expanding PM’s U.S. smoke-free portfolio and supporting its longer-term shift away from combustible tobacco. Smoke-free products, led by ZYN and IQOS, now account for more than 41% of revenue, offering a potential multiyear growth runway. Philip Morris’ ZYN ULTRA FDA Authorization Strengthens Smoke-Free Push
  • Positive Sentiment: Manufacturing agreements with Altria may improve efficiency. PM and Altria entered reciprocal contract-manufacturing arrangements involving cigarette production. The agreements should increase operational flexibility and manufacturing efficiency, with initial shipments expected in 2027. The partnership may provide longer-term cost and supply-chain benefits for PM, despite limited near-term earnings impact. Altria and Philip Morris International Sign Contract Manufacturing Deals
  • Positive Sentiment: Pricing power and shareholder returns remain supportive. PM’s portfolio spans IQOS, ZYN, VEEV One, and Marlboro, helping it maintain premium pricing amid uncertain economic conditions. Analysts highlight strong free cash flow, lower debt leverage, and the possibility of another dividend increase in September. Philip Morris: Big Tobacco With High-Growth Smoke-Free Assets
  • Neutral Sentiment: Near-term financial impact from the Altria deal is expected to be limited. Both companies said the manufacturing arrangements are not expected to materially affect 2026 results, so investors may need to wait until 2027 for measurable benefits. Altria vs. Philip Morris: What the New Manufacturing Deal Means for Investors
  • Negative Sentiment: Valuation leaves less room for disappointment. PM’s smoke-free growth and defensive cash flows have attracted a premium valuation, creating downside risk if product adoption, regulatory momentum, or earnings growth falls short of expectations.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on PM shares. Weiss Ratings reiterated a “buy (b)” rating on shares of Philip Morris International in a research report on Monday, August 17th. Needham & Company LLC lifted their target price on Philip Morris International from $200.00 to $215.00 and gave the company a “buy” rating in a research note on Thursday, July 23rd. Citigroup boosted their price target on Philip Morris International from $210.00 to $225.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Stifel Nicolaus increased their price target on Philip Morris International from $195.00 to $205.00 and gave the stock a “buy” rating in a research note on Thursday, July 23rd. Finally, BTIG Research set a $221.00 price target on Philip Morris International and gave the company a “buy” rating in a report on Friday, July 24th. Ten equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $205.89.

Get Our Latest Stock Analysis on PM

Philip Morris International Price Performance

NYSE PM opened at $194.00 on Wednesday. Philip Morris International Inc. has a 12 month low of $142.11 and a 12 month high of $207.76. The firm has a market capitalization of $302.36 billion, a PE ratio of 27.87, a P/E/G ratio of 2.31 and a beta of 0.38. The company’s 50 day simple moving average is $186.42 and its 200 day simple moving average is $178.55.

Philip Morris International (NYSE:PMGet Free Report) last issued its quarterly earnings results on Wednesday, July 22nd. The company reported $2.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.05 by $0.15. Philip Morris International had a negative return on equity of 163.41% and a net margin of 11.06%.The firm had revenue of $11.19 billion during the quarter, compared to analyst estimates of $10.60 billion. During the same period last year, the company posted $1.89 EPS. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. Sell-side analysts anticipate that Philip Morris International Inc. will post 8.33 earnings per share for the current fiscal year.

Philip Morris International Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, July 20th. Investors of record on Thursday, June 25th were issued a dividend of $1.47 per share. This represents a $5.88 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend was Thursday, June 25th. Philip Morris International’s payout ratio is presently 84.48%.

About Philip Morris International

(Free Report)

Philip Morris International Inc (NYSE: PM) is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.

PMI’s product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.

Featured Articles

Institutional Ownership by Quarter for Philip Morris International (NYSE:PM)

Receive News & Ratings for Philip Morris International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Philip Morris International and related companies with MarketBeat.com's FREE daily email newsletter.